on paper it looks like a smart move for clinical trials to be done where there is
a) an emerging financial market
b) access to greater clinical population
c) possibly less stringency and red tape.
I think with our financial position it makes sense to go this way. my worry is that the long term the data will not be as widely accepted as trials and data from more developed western countries would be. especially if the end game is FDA approval.
- Forums
- ASX - By Stock
- Ann: RCE Establishes Strategic Partnership in South-East Asia
on paper it looks like a smart move for clinical trials to be...
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
62.0¢ |
Change
0.025(4.20%) |
Mkt cap ! $126.4M |
Open | High | Low | Value | Volume |
62.0¢ | 62.0¢ | 60.0¢ | $15.11K | 24.88K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 9911 | 60.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
62.0¢ | 11623 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 9911 | 0.600 |
2 | 66328 | 0.595 |
2 | 1994 | 0.590 |
1 | 5215 | 0.575 |
1 | 33360 | 0.570 |
Price($) | Vol. | No. |
---|---|---|
0.620 | 11623 | 3 |
0.630 | 2000 | 1 |
0.645 | 50629 | 2 |
0.650 | 34260 | 1 |
0.655 | 6970 | 1 |
Last trade - 16.10pm 20/05/2024 (20 minute delay) ? |
|
|||||
Last
61.0¢ |
  |
Change
0.025 ( 0.81 %) |
|||
Open | High | Low | Volume | ||
60.0¢ | 61.5¢ | 60.0¢ | 4522 | ||
Last updated 15.59pm 20/05/2024 ? |
Featured News
RCE (ASX) Chart |